Abstract
Preoperative breast imaging plays an important role in selecting the appropriate breast-conserving surgery, and breast imaging before radiofrequency ablation (RFA) therapy is important for identifying eligible patients. Moreover, in order to ensure the safety of RFA, it is necessary to demonstrate its effects by postoperative imaging. However, there is currently only limited evidence of the usefulness of breast imaging after RFA therapy, and its utility for follow-up examination after breast-conserving surgery has not yet been elucidated.
In this chapter, we (1) describe the available follow-up imaging techniques after breast-conserving surgery, (2) explain the eligibility criteria for RFA therapy at our hospital, (3) describe early imaging after RFA therapy as a method of evaluating the results of RFA, (4) discuss the utility of postoperative follow-up RFA imaging, and (5) report the results of follow-up imaging after RFA therapy in our hospital.
Between 2006 and 2013, we performed a pilot study of RFA therapy without surgical excision for T1 breast cancer, and based on our results of this study, we believe that breast imaging before and after RFA therapy is very important.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.
Smith RA, Duffy SW, Gabe R et al. The randomized trials of breast cancer screening: what have we learned?. Radiol Clin North Am. 2004;42:793–806.
Belli P, Costantini M, Romani M, et al. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat. 2002;73:223–35.
Coulthard A, Beveridge CJ, Potterton AJ. MRI in routine breast cancer follow-up: correlation with clinical outcome. Clin Radiol. 1999;54(7):459–61.
Veronesi U, Luini A, Galimberti V, et al. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg. 1994;18:70–5.
El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245:665–71.
Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29:3885–91.
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106. Review.
Schiller DE, Le LW, Cho BC, et al. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol. 2008;15:833–42.
Waljee JF, Hu ES, Newman LA, et al. Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol. 2008;15:1297–303.
Kurniawan ED, Wong MH, Windle I, et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol. 2008;15:2542–9.
Davis PL, Staiger MJ, Harris KB, et al. Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat. 1996;37:1–9.
Susini T, Nori J, Olivieri S, Livi L, Bianchi S, Mangialavori G, et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma: a pilot study in elderly inoperable patients. Gynecol Oncol. 2007;104:304–10.
Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL MD, Nowels KW, Dirbas FM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg. 1999;134:1064–8.
Oura S, Tamaki T, Hirai I, Yoshimasu T, Ohta F, Nakamura R, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer. 2007;14:48–54.
Kinoshita T, Iwamoto E, Tsuda H, et al. Radiofrequency ablation as local therapy for early breast Carcinomas. Breast Cancer. 2011;18:10–7.
Nagashima T, Sakakibara M, Nakamura R, Arai M, Kadowaki M, Kazama T, et al. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients. Eur J Radiol. 2006;60:270–4.
Nagashima T, Suzuki M, Yagata H, Hashimoto H, Shishikura T, Imanaka N, et al. Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer. 2002;9:226–30.
Yamamoto N, Fujimoto H, Nakamura R, et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. Breast Cancer. 2011;18:3–9.
Ito T, Oura S, Yamamoto N, et al. Radiofrequency ablation of breast cancer. A multicenter retrospective analysis. J Clin Oncol 2012;30(15):suppl;abstr 1119.
Clinical Trial Registration URL:http://www.umin.ac.jp/ctr/index.htm. Unique identifier: UMIN000008675
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Nakamura, R., Yamamoto, N. (2016). Importance of Breast Imaging Before and After RFA Therapy. In: Kinoshita, T. (eds) Non-surgical Ablation Therapy for Early-stage Breast Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54463-0_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-54463-0_9
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54462-3
Online ISBN: 978-4-431-54463-0
eBook Packages: MedicineMedicine (R0)